{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T13:01:42Z","timestamp":1770555702706,"version":"3.49.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Dermatology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.clindermatol.2018.08.005","type":"journal-article","created":{"date-parts":[[2018,8,16]],"date-time":"2018-08-16T05:31:27Z","timestamp":1534397487000},"page":"756-764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Use of antiepileptic mood stabilizers in dermatology"],"prefix":"10.1016","volume":"36","author":[{"given":"Madhulika A.","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daiana R.","family":"Pur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Branka","family":"Vujcic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aditya K.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clindermatol.2018.08.005_bb0005","series-title":"Manual of Clinical Psychopharmacology","author":"Schatzberg","year":"2015"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0055","doi-asserted-by":"crossref","first-page":"18195","DOI":"10.1073\/pnas.0506624102","article-title":"Pharmacological modulation of pain-related brain activity during normal and central sensitization states in humans","volume":"102","author":"Iannetti","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0060","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clindermatol.2011.11.015","article-title":"Emotional regulation, dissociation, and the self-induced dermatoses: clinical features and implications for treatment with mood stabilizers","volume":"31","author":"Gupta","year":"2013","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0065","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/S0140-6736(98)05418-X","article-title":"Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis during first weeks of antiepileptic therapy: a case-control study. Study Group of the International Case Control Study on Severe Cutaneous Adverse Reactions","volume":"353","author":"Rzany","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0070","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/epi.12564","article-title":"Recommendations for HLA-B*15:02 and HLA-A*31:01 genetic testing to reduce the risk of carbamazepine-induced hypersensitivity reactions","volume":"55","author":"Amstutz","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0075","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1212\/01.wnl.0000334295.50403.4c","article-title":"Cross-sensitivity of skin rashes with antiepileptic drug use","volume":"71","author":"Hirsch","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0080","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.pharep.2014.11.009","article-title":"Antiepileptic drugs and adverse skin reactions: An update","volume":"67","author":"Blaszczyk","year":"2015","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0085","series-title":"Basic & Clinical Pharmacology","first-page":"396","article-title":"Antiseizure drugs","author":"Porter","year":"2015"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0090","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/AJP.0b013e3181673b93","article-title":"Effect of chronic oral gabapentin on capsaicin-induced pain and hyperalgesia: a double-blind, placebo-controlled, crossover study","volume":"24","author":"Wallace","year":"2008","journal-title":"Clin J Pain"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0095","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1093\/bja\/ael344","article-title":"Effects of oral pregabalin and aprepitant on pain and central sensitization in the electrical hyperalgesia model in human volunteers","volume":"98","author":"Chizh","year":"2007","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0100","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1097\/00000542-200412000-00021","article-title":"Chronic oral gabapentin reduces elements of central sensitization in human experimental hyperalgesia","volume":"101","author":"Gottrup","year":"2004","journal-title":"Anesthesiology"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0105","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1016\/j.jaad.2007.07.017","article-title":"Pregabalin in the treatment of chronic pruritus","volume":"58","author":"Ehrchen","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0110","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.pain.2010.09.030","article-title":"Central sensitization: implications for the diagnosis and treatment of pain","volume":"152","author":"Woolf","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0115","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3233\/BMR-160685","article-title":"Central sensitization in chronic low back pain: A narrative review","volume":"29","author":"Sanzarello","year":"2016","journal-title":"J Back Musculoskelet Rehabil"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0120","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1046\/j.1365-2133.2002.04806.x","article-title":"Topiramate in the treatment of psoriasis: a pilot study","volume":"147","author":"Ryback","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0125","first-page":"18","article-title":"Inflammatory linear verrucous epidermal nevus and epilepsy: remission during valproic acid therapy","volume":"12","author":"Diluvio","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0130","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0006-8993(99)02439-7","article-title":"Sodium valproate inhibits production of TNF-alpha and IL-6 and activation of NF-kappaB","volume":"857","author":"Ichiyama","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0135","first-page":"1298","article-title":"Valproic acid enhances cisplatin cytotoxicity in melanoma cells","volume":"69","author":"Chodurek","year":"2012","journal-title":"Acta Pol Pharm"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0140","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1001\/archderm.141.12.1507","article-title":"Efficacy of gabapentin in the management of pruritus of unknown origin","volume":"141","author":"Yesudian","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0145","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1049909112445464","article-title":"Gabapentin for pruritus in palliative care","volume":"30","author":"Anand","year":"2013","journal-title":"Am J Hosp Palliat Care"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0150","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMcp1208814","article-title":"Clinical practice. Chronic pruritus","volume":"368","author":"Yosipovitch","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0155","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21370","article-title":"Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial","volume":"44","author":"Bergasa","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0160","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.semnephrol.2015.06.009","article-title":"Pruritus in kidney disease","volume":"35","author":"Combs","year":"2015","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0165","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/ndt\/gfh496","article-title":"Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial","volume":"19","author":"Gunal","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0170","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/08860220802595476","article-title":"Gabapentin and uremic pruritus in hemodialysis patients","volume":"31","author":"Razeghi","year":"2009","journal-title":"Ren Fail"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0175","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jpainsymman.2012.03.001","article-title":"Use of pregabalin in the management of chronic uremic pruritus","volume":"45","author":"Shavit","year":"2013","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0180","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1440-1797.2012.01655.x","article-title":"Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study","volume":"17","author":"Solak","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0185","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.burns.2011.12.003","article-title":"Post burn pruritus\u2014a review of current treatment options","volume":"38","author":"Zachariah","year":"2012","journal-title":"Burns"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0190","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.burns.2012.09.016","article-title":"A four arm, double blind, randomized and placebo controlled study of pregabalin in the management of post-burn pruritus","volume":"39","author":"Ahuja","year":"2013","journal-title":"Burns"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0195","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jaad.2006.04.025","article-title":"Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma","volume":"55","author":"Demierre","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0200","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.psym.2012.08.006","article-title":"Psychogenic itch responding to topiramate","volume":"54","author":"Calabro","year":"2013","journal-title":"Psychosomatics"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0205","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/j.1468-3083.2007.02256.x","article-title":"Gabapentin treatment for notalgia paresthetica, a common isolated peripheral sensory neuropathy","volume":"21","author":"Loosemore","year":"2007","journal-title":"J Eur Acad Dermatol Neurol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0210","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1590\/abd1806-4841.20142777","article-title":"Efficacy of gabapentin in the improvement of pruritus and quality of life of patients with notalgia paresthetica","volume":"89","author":"Maciel","year":"2014","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0215","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1346-8138.2010.00830.x","article-title":"Brachioradial pruritus successfully treated with gabapentin","volume":"37","author":"Yilmaz","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0220","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.0007-0963.2004.05889.x","article-title":"Brachioradial pruritus: response to treatment with gabapentin","volume":"150","author":"Winhoven","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0225","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1034\/j.1600-0404.2000.0006a.x","article-title":"Gabapentin use in neuropathic pain syndromes","volume":"101","author":"Nicholson","year":"2000","journal-title":"Acta Neurol Scand"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0230","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1046\/j.0003-2409.2001.02399.x","article-title":"Gabapentin: pharmacology and its use in pain management","volume":"57","author":"Rose","year":"2002","journal-title":"Anaesthesia"},{"issue":"Suppl A","key":"10.1016\/j.clindermatol.2018.08.005_bb0235","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1053\/eujp.2001.0324","article-title":"Anticonvulsants in neuropathic pain: rationale and clinical evidence","volume":"6","author":"Jensen","year":"2002","journal-title":"Eur J Pain"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0240","first-page":"421","article-title":"Lamotrigine in the treatment of pain syndromes and neuropathic pain","volume":"109","author":"Titlic","year":"2008","journal-title":"Bratisl Lek Listy"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0245","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jpainsymman.2006.12.015","article-title":"Double-blind, placebo-controlled trial of lamotrigine in combination with other medications for neuropathic pain","volume":"34","author":"Silver","year":"2007","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0250","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1526-4637.2010.00859.x","article-title":"A fMRI evaluation of lamotrigine for the treatment of trigeminal neuropathic pain: pilot study","volume":"11","author":"Scrivani","year":"2010","journal-title":"Pain Med"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0255","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0304-3959(02)00255-5","article-title":"Gabapentin in neuropathic pain syndromes: a randomised, double-blind, placebo-controlled trial","volume":"99","author":"Serpell","year":"2002","journal-title":"Pain"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0260","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1067\/mjd.2002.107970","article-title":"Gabapentin treatment of multiple piloleiomyoma-related pain","volume":"46","author":"Alam","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0265","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.jpainsymman.2009.03.001","article-title":"Successful pain relief of cutaneous leiomyomata due to reed syndrome with the combination treatment of pregabalin and duloxetine","volume":"38","author":"Kostopanagiotou","year":"2009","journal-title":"J Pain Symptom Manag"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0270","doi-asserted-by":"crossref","DOI":"10.5070\/D3219028697","article-title":"Two sisters with Reed\u2019s syndrome: treatment with pregabalin","volume":"21","author":"Yaldiz","year":"2015","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0275","first-page":"E705","article-title":"Comparative efficacy and safety of six antidepressants and anticonvulsants in painful diabetic neuropathy: a network meta-analysis","volume":"16","author":"Rudroju","year":"2013","journal-title":"Pain Physician"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0280","doi-asserted-by":"crossref","first-page":"110","DOI":"10.12788\/j.sder.0010","article-title":"Cutaneous sensory disorder","volume":"32","author":"Gupta","year":"2013","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0285","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1001\/jamadermatol.2013.914","article-title":"Scalp dysesthesia related to cervical spine disease","volume":"149","author":"Thornsberry","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0290","doi-asserted-by":"crossref","first-page":"e635","DOI":"10.4317\/medoral.16942","article-title":"Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of burning mouth syndrome: a randomized, double-blind, placebo controlled trial","volume":"16","author":"L\u00f3pez-D\u2019alessandro","year":"2011","journal-title":"Med Oral Patol Oral Cir Bucal"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0295","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1001\/archotol.130.6.786","article-title":"Effectiveness of gabapentin for treatment of burning mouth syndrome","volume":"130","author":"White","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0300","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1046\/j.1365-2230.2002.10743.x","article-title":"Gabapentin\u2014a promising treatment in glossodynia","volume":"27","author":"Meiss","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0305","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1111\/j.1365-2230.2009.03493.x","article-title":"Marked response of burning mouth syndrome to pregabalin treatment","volume":"34","author":"L\u00f3pez","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0310","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/WNF.0000000000000093","article-title":"Five patients with burning mouth syndrome in whom an antidepressant (serotonin-noradrenaline reuptake inhibitor) was not effective, but pregabalin markedly relieved pain","volume":"38","author":"Ito","year":"2015","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0315","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1526-4637.2006.00152.x","article-title":"Use of topiramate for glossodynia","volume":"8","author":"Siniscalchi","year":"2007","journal-title":"Pain Med"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0320","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/GRF.0000000000000093","article-title":"Vulvodynia","volume":"58","author":"Edwards","year":"2015","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0325","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/0167482X.2013.823942","article-title":"Anticonvulsant pharmacotherapy for generalized and localized vulvodynia: a critical review of the literature","volume":"34","author":"Spoelstra","year":"2013","journal-title":"J Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0330","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1155\/2007\/265148","article-title":"Pregabalin-induced remission in a 62-year-old woman with a 20-year history of vulvodynia","volume":"12","author":"Jerome","year":"2007","journal-title":"Pain Res Manag"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0335","first-page":"171","article-title":"Open-label trial of lamotrigine focusing on efficacy in vulvodynia","volume":"54","author":"Meltzer-Brody","year":"2009","journal-title":"J Reprod Med"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0340","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/j.1365-4632.2011.05158.x","article-title":"Women with scalp dysesthesia treated with pregabalin","volume":"52","author":"Sarifakioglu","year":"2013","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0345","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1001\/archderm.1963.01590240183031","article-title":"Behavior disorders of interest to dermatologists","volume":"88","author":"Butterworth","year":"1963","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0350","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0163-8343(87)90101-0","article-title":"The self-inflicted dermatoses: a critical review","volume":"9","author":"Gupta","year":"1987","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0355","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0360","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/pcn.12186","article-title":"Potential role of anticonvulsants in the treatment of obsessive\u2013compulsive and related disorders","volume":"68","author":"Wang","year":"2014","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0365","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.4088\/JCP.v68n0909","article-title":"Lamotrigine treatment of pathologic skin picking: an open-label study","volume":"68","author":"Grant","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0370","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/JCP.0b013e3181e617a1","article-title":"A double-blind, placebo-controlled trial of lamotrigine for pathological skin picking: treatment efficacy and neurocognitive predictors of response","volume":"30","author":"Grant","year":"2010","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0375","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/JCP.0000000000000462","article-title":"Systematic review of pharmacological and behavioral treatments for skin picking disorder","volume":"36","author":"Schumer","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0380","first-page":"CD007662","article-title":"Pharmacotherapy for trichotillomania","volume":"8","author":"Rothbart","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0385","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00004850-200609000-00002","article-title":"Topiramate in the treatment of trichotillomania: an open-label pilot study","volume":"21","author":"Lochner","year":"2006","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0390","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1089\/cap.2008.076","article-title":"Trichotillomania: a case of response to valproic acid","volume":"18","author":"Adewuya","year":"2008","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0395","first-page":"42","article-title":"Topiramate and scars","volume":"11","author":"Bharti","year":"2005","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0400","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1529-8019.2010.01314.x","article-title":"Therapeutic hotline: Treatment of prurigo nodularis and lichen simplex chronicus with gabapentin","volume":"23","author":"Gencoglan","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0405","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.2169\/internalmedicine.52.0060","article-title":"Successful treatment of chronic intractable itching using oral pregabalin in a patient with diabetes and systemic prurigo nodularis: a case report of an iliopsoas muscle abscess","volume":"52","author":"Imai","year":"2013","journal-title":"Intern Med"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0410","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000330559","article-title":"Efficacy of paroxetine in primary palmoplantar hyperhidrosis occurring with juvenile myoclonic epilepsy","volume":"223","author":"Katshu","year":"2011","journal-title":"Dermatology"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0415","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/09540261.2012.736367","article-title":"Review of somatic symptoms in post-traumatic stress disorder","volume":"25","author":"Gupta","year":"2013","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0420","first-page":"A271","article-title":"Night sweating, suicidality and autonomic nervous system (ANS) hyperarousal in posttraumatic stress disorder (PTSD): clinical features and treatment with mood stabilizers","volume":"37","author":"Gupta","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0425","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1046\/j.1365-2133.2003.05237.x","article-title":"The suppression of primary palmar-plantar hyperhidrosis by topiramate","volume":"148","author":"Owen","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0430","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.clindermatol.2012.01.012","article-title":"Chronic idiopathic urticaria and post-traumatic stress disorder (PTSD): an under-recognized comorbidity","volume":"30","author":"Gupta","year":"2012","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0435","first-page":"79","article-title":"Association of neurogenic rosacea and chronic posttruamatic stress disorder (PTSD): possible role of autonomic nervous system dysregulation and high sympathetic tone in PTSD (Conference abstract)","volume":"277S","author":"Gupta","year":"2016","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clindermatol.2018.08.005_bb0440","doi-asserted-by":"crossref","first-page":"419","DOI":"10.2165\/0128071-200809060-00012","article-title":"Improvement in psoriasis following treatment with gabapentin and pregabalin","volume":"9","author":"Boyd","year":"2008","journal-title":"Am J Dermatol"}],"container-title":["Clinics in Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X18301767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0738081X18301767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T11:06:22Z","timestamp":1661771182000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0738081X18301767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":79,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0738081X18301767"],"URL":"https:\/\/doi.org\/10.1016\/j.clindermatol.2018.08.005","relation":{},"ISSN":["0738-081X"],"issn-type":[{"value":"0738-081X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of antiepileptic mood stabilizers in dermatology","name":"articletitle","label":"Article Title"},{"value":"Clinics in Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clindermatol.2018.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}